Gestational Diabetes
397
50
73
191
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
24 trials with published results (6%)
Research Maturity
191 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
16 terminated out of 397 trials
92.3%
+5.7% vs benchmark
7%
28 trials in Phase 3/4
13%
24 of 191 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 191 completed trials
Clinical Trials (397)
Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Usability Study of the Sensors and eMOM GDM Application
eHealth in Treatment of Gestational Diabetes (eMOMGDM)
Nutrition Optimization and Community Upliftment for Postpartum Recovery
Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes
Harnessing Human Potential and Improving Health Span in Women and Their Children
The Use of Social Media Platform to Continuously Support Pregnant Women With Gestational Diabetes Mellitus
Nutcracker: Can Almond Nut Consumption Improve Nocturnal Glycaemic Control in Women With Gestational Diabetes Mellitus?
Glucose and Blood Pressure During Pregnancy
Presessions for the National Diabetes Prevention Program
EARLY Pregnancy GLucose prOfiles in Women With and Without GDM Risk Factors: EARLY-GLOW
Lifestyle Interventions to Improve Glycemic Parameters and Reduce Gestational Diabetes in High-risk Pregnant Individuals
Group Versus Traditional Prenatal Care for Diabetes
Biomarkers During Pregnancy
Preventing T2DM After GDM With Immediate Postpartum Screening
Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)
Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus